Dario Lidonnici
Publications by Year
Research Areas
Health Systems, Economic Evaluations, Quality of Life, Pharmaceutical Economics and Policy, Biosimilars and Bioanalytical Methods, Biomedical Ethics and Regulation, Hepatitis C virus research
Most-Cited Works
- → Mutant Copper-Zinc Superoxide Dismutase (SOD1) Induces Protein Secretion Pathway Alterations and Exosome Release in Astrocytes(2013)267 cited
- → Lack of TNF‐alpha receptor type 2 protects motor neurons in a cellular model of amyotrophic lateral sclerosis and in mutant SOD1 mice but does not affect disease progression(2015)36 cited
- → Lentiviral vectors carrying enhancer elements of Hb9 promoter drive selective transgene expression in mouse spinal cord motor neurons(2012)24 cited
- → Do France, Germany, and Italy agree on the added therapeutic value of medicines?(2023)12 cited
- → Tempi di accesso ai farmaci in Italia nel periodo 2015-2017: Analisi delle tempistiche di valutazione dell’Agenzia Italiana del Farmaco(2018)7 cited
- → Economic assessment of eltrombopag in the treatment of thrombocytopenia(2015)5 cited
- → AIFA time-to-reimbursement: a comparison between the last two committees from 2015 to 2020(2020)5 cited
- → The management of achondroplasia in Italy: results from a Delphi panel based on real-world experience(2023)4 cited
- → Expert Insights from a Delphi-driven Neurologists’ Panel: Real-world Mexiletine use in Patients with Myotonic Disorders in Italy(2024)3 cited
- → New Drugs Approval In Italy: Analysis Of The Applied Negotiation Conditions 2015-2017(2017)1 cited